Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenetic protein-2-based matrices.
Journal: 2006/September - Tissue engineering
ISSN: 1076-3279
Abstract:
Extracellular matrix (ECM) molecules in cartilage cooperate with growth factors to regulate chondrogenic differentiation and cartilage development. Domain I of perlecan (Pln) bears heparan sulfate chains that bind and release heparin binding growth factors (HBGFs). We hypothesized that Pln domain I (PlnDI) might be complexed with collagen II (P-C) fibrils to improve binding of bone morphogenetic protein-2 (BMP-2) and better support chondrogenesis and cartilage-like tissue formation in vitro. Our results showed that P-C fibrils bound more BMP-2 than collagen II fibrils alone, and better sustained BMP-2 release. Polylactic acid (PLA)-based scaffolds coated with P-C fibrils immobilized more BMP-2 than either PLA scaffolds or PLA scaffolds coated with collagen II fibrils alone. Multipotential mouse embryonic mesenchymal cells, C3H10T1/2, were cultured on 2-dimensional P-C fibrils or 3-dimensional P-C/BMP-2-coated (P-C-B) PLA scaffolds. Chondrogenic differentiation was indexed by glycosaminoglycan (GAG) production, and expression of the pro-chondrogenic transcription factor, Sox9, as well as cartilaginous ECM proteins, collagen II, and aggrecan. Immunostaining for aggrecan, perlecan, tenascin, and collagen X revealed that both C3H10T1/2 cells and primary mouse embryonic fibroblasts cultured on P-C-B fibrils showed the highest expression of chondrogenic markers among all treatment groups. Safranin O-Fast Green staining indicated that cartilage-like tissue was formed in the P-C-B scaffolds, while no obvious cartilage-like tissue formed in other scaffolds. We conclude that P-C fibrils provide an improved biomimetic material for the binding and retention of BMP-2 and support chondrogenic differentiation.
Relations:
Content
Citations
(24)
References
(57)
Grants
(1)
Chemicals
(6)
Organisms
(2)
Processes
(1)
Anatomy
(5)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Tissue Eng 12(7): 2009-2024

Chondrogenic Differentiation on Perlecan Domain I, Collagen II and Bone Morphogenetic Protein 2-Based Matrices

Department of Biological Sciences, University of Delaware, Newark, DE, 19716 USA
To whom correspondence should be addressed: Phone: 302-831-6977, Fax: 302-831-1033, E-mail: ude.ledu@nosracd
Current Address: Department of Orthopaedics & Rehabilitation, Pennsylvania State College of Medicine, Hershey, PA 17033

Abstract

Extracellular matrix (ECM) molecules in cartilage, cooperate with growth factors to regulate chondrogenic differentiation and cartilage development. Domain I of perlecan (Pln) bears heparan sulfate chains that bind and release heparin binding growth factors (HBGFs). Our hypothesis was that Pln domain I (PlnDI) might be complexed with collagen II (P-C) fibrils to improve binding of bone morphogenetic protein-2 (BMP-2) and better support chondrogenesis and cartilage-like tissue formation in vitro. Our results showed that P-C fibrils bound more BMP-2 than collagen II fibrils alone, and better sustained BMP-2 release. Polylactic acid (PLA)-based scaffolds coated with P-C fibrils immobilized more BMP-2 than either PLA scaffolds or PLA scaffolds coated with collagen II fibrils alone. Multipotential mouse embryonic mesenchymal cells, C3H10T1/2, were cultured on two-dimensional P-C fibrils or three dimensional P-C/BMP-2-coasted (P-C-B) PLA scaffolds. Chondrogenic differentiation was indexed by glycosaminoglycan (GAG) production, and expression of the pro-chondrogenic transcription factor, Sox9, as well as cartilaginous ECM proteins, collagen II and aggrecan. Immunostaining for aggrecan, perlecan, tenascin and collagen X revealed that both C3H10T1/2 cells and primary mouse embryonic fibroblasts cultured on P-C-B fibrils showed the highest expression of chondrogenic markers among all treatment groups. Safranin O-Fast Green staining indicated that cartilage-like tissue was formed in the P-C-B scaffolds, while no obvious cartilage-like tissue formed in other scaffolds. We have concluded that P-C fibrils provide an improved biomimetic material for the binding and retention of BMP-2 and support chondrogenenic differentiation.

Keywords: Chondrogenesis, Perlecan, Bone Morphogenetic Protein-2 (BMP-2), Collagen II, Mesenchymal Cells, Tissue Engineering
Abstract

References

  • 1. Poole AR, Kojima T, Yasuda T, Mwale F, Kobayashi M, Laverty SComposition and structure of articular cartilage: a template for tissue repair. Clin Orthop Relat Res. 2001:S26.[PubMed][Google Scholar]
  • 2. Knudson CB, Knudson WCartilage proteoglycans. Semin Cell Dev Biol. 2001;12:69.[PubMed][Google Scholar]
  • 3. Gustafsson E, Aszodi A, Ortega N, Hunziker EB, Denker HW, Werb Z, Fassler RRole of collagen type II and perlecan in skeletal development. Ann N Y Acad Sci. 2003;995:140.[PubMed][Google Scholar]
  • 4. Gomes RR, Jr., Farach-Carson MC, Carson DDPerlecan functions in chondrogenesis: insights from in vitro and in vivo models. Cells Tissues Organs. 2004;176:79.[PubMed][Google Scholar]
  • 5. Murdoch AD, Dodge GR, Cohen I, Tuan RS, Iozzo RV. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J Biol Chem. 1992;267:8544.[PubMed]
  • 6. Kirn-Safran CB, Gomes RR, Brown AJ, Carson DDHeparan sulfate proteoglycans: coordinators of multiple signaling pathways during chondrogenesis. Birth Defects Res C Embryo Today. 2004;72:69.[PubMed][Google Scholar]
  • 7. Yang WD, Gomes RR, Jr., Alicknavitch M, Farach-Carson MC, Carson DDPerlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds. Tissue Eng. 2005;11:76.[Google Scholar]
  • 8. Knox S, Merry C, Stringer S, Melrose J, Whitelock JNot all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors. J Biol Chem. 2002;277:14657.[PubMed][Google Scholar]
  • 9. Jiang X, Couchman JRPerlecan and tumor angiogenesis. J Histochem Cytochem. 2003;51:1393.[Google Scholar]
  • 10. Ruppert R, Hoffmann E, Sebald WHuman bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur J Biochem. 1996;237:295.[PubMed][Google Scholar]
  • 11. Takada T, Katagiri T, Ifuku M, Morimura N, Kobayashi M, Hasegawa K, Ogamo A, Kamijo RSulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem. 2003;278:43229.[PubMed][Google Scholar]
  • 12. Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada YPerlecan is essential for cartilage and cephalic development. Nat Genet. 1999;23:354.[PubMed][Google Scholar]
  • 13. Kosir MA, Quinn CC, Wang W, Tromp GMatrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing. J Surg Res. 2000;92:45.[PubMed][Google Scholar]
  • 14. French MM, Smith SE, Akanbi K, Sanford T, Hecht J, Farach-Carson MC, Carson DDExpression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. J Cell Biol. 1999;145:1103.[Google Scholar]
  • 15. Handler M, Yurchenco PD, Iozzo RVDevelopmental expression of perlecan during murine embryogenesis. Dev Dyn. 1997;210:130.[PubMed][Google Scholar]
  • 16. Aszodi A, Bateman JF, Gustafsson E, Boot-Handford R, Fassler RMammalian skeletogenesis and extracellular matrix: what can we learn from knockout mice? Cell Struct Funct. 2000;25:73.[PubMed][Google Scholar]
  • 17. Costell M, Gustafsson E, Aszodi A, Morgelin M, Bloch W, Hunziker E, Addicks K, Timpl R, Fassler RPerlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol. 1999;147:1109.[Google Scholar]
  • 18. Hassell J, Yamada Y, Arikawa-Hirasawa ERole of perlecan in skeletal development and diseases. Glycoconj J. 2002;19:263.[PubMed][Google Scholar]
  • 19. French MM, Gomes RR, Jr., Timpl R, Hook M, Czymmek K, Farach-Carson MC, Carson DDChondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I. J Bone Miner Res. 2002;17:48.[Google Scholar]
  • 20. Gomes RR, Jr., Farach Carson MC, Carson DDPerlecan-stimulated nodules undergo chondrogenic maturation in response to rhBMP-2 treatment in vitro. Connect Tissue Res. 2003;44(Suppl 1):196.[Google Scholar]
  • 21. Miller SA, Brown AJ, Farach-Carson MC, Kirn-Safran CBHIP/RPL29 down-regulation accompanies terminal chondrocyte differentiation. Differentiation. 2003;71:322.[PubMed][Google Scholar]
  • 22. Paine-Saunders S, Viviano BL, Economides AN, Saunders SHeparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients. J Biol Chem. 2002;277:2089.[PubMed][Google Scholar]
  • 23. Hedbom E, Heinegard DBinding of fibromodulin and decorin to separate sites on fibrillar collagens. J Biol Chem. 1993;268:27307.[PubMed][Google Scholar]
  • 24. Oldberg A, Antonsson P, Lindblom K, Heinegard DA collagen-binding 59-kd protein (fibromodulin) is structurally related to the small interstitial proteoglycans PG-S1 and PG-S2 (decorin) Embo J. 1989;8:2601.[Google Scholar]
  • 25. Vynios DH, Papageorgakopoulou N, Sazakli H, Tsiganos CPThe interactions of cartilage proteoglycans with collagens are determined by their structures. Biochimie. 2001;83:899.[PubMed][Google Scholar]
  • 26. Hedlund H, Hedbom E, Heinegard D, Mengarelli-Widholm S, Reinholt FP, Svensson OAssociation of the aggrecan keratan sulfate-rich region with collagen in bovine articular cartilage. J Biol Chem. 1999;274:5777.[PubMed][Google Scholar]
  • 27. Smith GN, Jr., Williams JM, Brandt KDInteraction of proteoglycans with the pericellular (1 alpha, 2 alpha, 3 alpha) collagens of cartilage. J Biol Chem. 1985;260:10761.[PubMed][Google Scholar]
  • 28. San Antonio JD, Karnovsky MJ, Gay S, Sanderson RD, Lander ADInteractions of syndecan-1 and heparin with human collagens. Glycobiology. 1994;4:327.[PubMed][Google Scholar]
  • 29. Munakata H, Takagaki K, Majima M, Endo MInteraction between collagens and glycosaminoglycans investigated using a surface plasmon resonance biosensor. Glycobiology. 1999;9:1023.[PubMed][Google Scholar]
  • 30. Zhu Y, Oganesian A, Keene DR, Sandell LJType IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-beta1 and BMP-2. J Cell Biol. 1999;144:1069.[Google Scholar]
  • 31. Sieron AL, Louneva N, Fertala ASite-specific interaction of bone morphogenetic protein 2 with procollagen II. Cytokine. 2002;18:214.[PubMed][Google Scholar]
  • 32. Fertala A, Han WB, Ko FKMapping critical sites in collagen II for rational design of gene-engineered proteins for cell-supporting materials. J Biomed Mater Res. 2001;57:48.[PubMed][Google Scholar]
  • 33. Nehrer S, Breinan HA, Ramappa A, Shortkroff S, Young G, Minas T, Sledge CB, Yannas IV, Spector MCanine chondrocytes seeded in type I and type II collagen implants investigated in vitro. J Biomed Mater Res. 1997;38:95.[PubMed][Google Scholar]
  • 34. Veilleux NH, Yannas IV, Spector MEffect of passage number and collagen type on the proliferative, biosynthetic, and contractile activity of adult canine articular chondrocytes in type I and II collagen-glycosaminoglycan matrices in vitro. Tissue Eng. 2004;10:119.[PubMed][Google Scholar]
  • 35. Hsu SH, Tsai CL, Tang CMEvaluation of cellular affinity and compatibility to biodegradable polyesters and Type-II collagen-modified scaffolds using immortalized rat chondrocytes. Artif Organs. 2002;26:647.[PubMed][Google Scholar]
  • 36. Taguchi T, Ikoma T, Tanaka JAn improved method to prepare hyaluronic acid and type II collagen composite matrices. J Biomed Mater Res. 2002;61:330.[PubMed][Google Scholar]
  • 37. Pieper JS, van der Kraan PM, Hafmans T, Kamp J, Buma P, van Susante JL, van den Berg WB, Veerkamp JH, van Kuppevelt THCrosslinked type II collagen matrices: preparation, characterization, and potential for cartilage engineering. Biomaterials. 2002;23:3183.[PubMed][Google Scholar]
  • 38. Lee V, Cao L, Zhang Y, Kiani C, Adams ME, Yang BBThe roles of matrix molecules in mediating chondrocyte aggregation, attachment, and spreading. J Cell Biochem. 2000;79:322.[PubMed][Google Scholar]
  • 39. Buma P, Pieper JS, van Tienen T, van Susante JL, van der Kraan PM, Veerkamp JH, van den Berg WB, Veth RP, van Kuppevelt THCross-linked type I and type II collagenous matrices for the repair of full-thickness articular cartilage defects--a study in rabbits. Biomaterials. 2003;24:3255.[PubMed][Google Scholar]
  • 40. Mueller SM, Shortkroff S, Schneider TO, Breinan HA, Yannas IV, Spector MMeniscus cells seeded in type I and type II collagen-GAG matrices in vitro. Biomaterials. 1999;20:701.[PubMed][Google Scholar]
  • 41. Hall BK, Miyake TAll for one and one for all: condensations and the initiation of skeletal development. Bioessays. 2000;22:138.[PubMed][Google Scholar]
  • 42. Tuan RSBiology of developmental and regenerative skeletogenesis. Clin Orthop Relat Res. 2004:S105.[PubMed][Google Scholar]
  • 43. Lengner CJ, Lepper C, van Wijnen AJ, Stein JL, Stein GS, Lian JBPrimary mouse embryonic fibroblasts: a model of mesenchymal cartilage formation. J Cell Physiol. 2004;200:327.[PubMed][Google Scholar]
  • 44. Schmitt B, Ringe J, Haupl T, Notter M, Manz R, Burmester GR, Sittinger M, Kaps CBMP2 initiates chondrogenic lineage development of adult human mesenchymal stem cells in high-density culture. Differentiation. 2003;71:567.[PubMed][Google Scholar]
  • 45. Shea CM, Edgar CM, Einhorn TA, Gerstenfeld LCBMP treatment of C3H10T1/2 mesenchymal stem cells induces both chondrogenesis and osteogenesis. J Cell Biochem. 2003;90:1112.[PubMed][Google Scholar]
  • 46. Seghatoleslami MR, Tuan RSCell density dependent regulation of AP-1 activity is important for chondrogenic differentiation of C3H10T1/2 mesenchymal cells. J Cell Biochem. 2002;84:237.[PubMed][Google Scholar]
  • 47. Hanada K, Solchaga LA, Caplan AI, Hering TM, Goldberg VM, Yoo JU, Johnstone BBMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. J Cell Biochem. 2001;81:284.[PubMed][Google Scholar]
  • 48. Bergman I, Loxley RNew spectrophotometric method for the determination of proline in tissue hydrolyzates. Anal Chem. 1970;42:702.[PubMed][Google Scholar]
  • 49. Izzo MW, Pucci B, Tuan RS, Hall DJGene expression profiling following BMP-2 induction of mesenchymal chondrogenesis in vitro. Osteoarthritis Cartilage. 2002;10:23.[PubMed][Google Scholar]
  • 50. Atkinson BL, Fantle KS, Benedict JJ, Huffer WE, Gutierrez-Hartmann ACombination of osteoinductive bone proteins differentiates mesenchymal C3H/10T1/2 cells specifically to the cartilage lineage. J Cell Biochem. 1997;65:325.[PubMed][Google Scholar]
  • 51. Chen G, Ushida T, Tateishi TPoly(DL-lactic-co-glycolic acid) sponge hybridized with collagen microsponges and deposited apatite particulates. J Biomed Mater Res. 2001;57:8.[PubMed][Google Scholar]
  • 52. Unsworth JM, Rose FR, Wright E, Scotchford CA, Shakesheff KMSeeding cells into needled felt scaffolds for tissue engineering applications. J Biomed Mater Res. 2003;A 66:425.[PubMed][Google Scholar]
  • 53. Shin H, Jo S, Mikos AGBiomimetic materials for tissue engineering. Biomaterials. 2003;24:4353.[PubMed][Google Scholar]
  • 54. Noth U, Tuli R, Osyczka AM, Danielson KG, Tuan RSIn vitro engineered cartilage constructs produced by press-coating biodegradable polymer with human mesenchymal stem cells. Tissue Eng. 2002;8:131.[PubMed][Google Scholar]
  • 55. Nerlich AG Histochemical and immunohistochemical staining of cartilage sections. Humana Press Inc.; Totowa, New Jersey: 2003. [PubMed][Google Scholar]
  • 56. Yang WD, Chen SJ, Mao TQ, Chen FL, Lei DL, Tao K, Tang LH, Xiao MGA study of injectable tissue-engineered autologous cartilage. Chin J Dent Res. 2000;3:10.[PubMed][Google Scholar]
  • 57. Jones FS, Jones PLThe tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn. 2000;218:235.[PubMed][Google Scholar]
  • 58. Qi WN, Scully SPType II collagen modulates the composition of extracellular matrix synthesized by articular chondrocytes. J Orthop Res. 2003;21:282.[PubMed][Google Scholar]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.